Skip to content

Sevoflurane Versus Propofol in Endovascular Coiling of Cerebral Aneurysm

Comparison of the Neuroprotective Effect of Sevoflurane Versus Propofol in Patients Undergoing Endovascular Coiling of Cerebral Aneurysm

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06666959
Enrollment
80
Registered
2024-10-31
Start date
2023-05-01
Completion date
2024-05-08
Last updated
2024-10-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Propofol, Sevoflurane

Brief summary

The goal of this observational study is to learn about the anti-inflammatory effects of anesthetics on patients undergoing endovascular coiling of cerebral aneurysm. The main question it aims to answer is: Does sevoflurane or propofol affect the inflammatory response in subarachnoid hemorrhage? Participants already undergoing endovascular coiling of cerebral aneurysm will have their serum levels of inflammatory factors measured.

Interventions

intravenous anesthetic and inhalation anesthetic

Sponsors

Tongji Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Consecutive patients aged 18 years and older presenting to the Tongji hospital for endovascular coiling of cerebral aneurysm were eligible for enrollment.

Exclusion criteria

* have an endocrine system disease * pregnancy * have other brain disorders * take drugs that alter endocrine hormones * receive perioperative blood derivatives

Design outcomes

Primary

MeasureTime frameDescription
Concentration of interleukin-10From enrollment to 3 months postoperationTest the concentration of interleukin-10 of the participants

Secondary

MeasureTime frameDescription
Concentration of interleukin-2From enrollment to 3 months postoperationTest the concentration of interleukin-2 in participants
Concentration of interleukin-6From enrollment to 3 months postoperationTest the concentration of interleukin-6 in participants
Concentration of interleukin-8From enrollment to 3 months postoperationTest the concentration of interleukin-8 in participants
Concentration of tumor necrosis factorFrom enrollment to 3 months postoperationTest the concentration of tumor necrosis factor in participants
Concentration of interleukin-1From enrollment to 3 months postoperationTest the Concentration of interleukin-1 in participants
length of staythrough study completion, an average of 6 monthsThe time from admission to discharge
coststhrough study completion, an average of 6 monthsHospitalization expenses
Glasgow Coma ScoreFrom enrollment to 3 months postoperationThe scores are ranging from 3 to 15. And higher scores mean a betterr outcome .
Concentration of S100BFrom enrollment to 3 months postoperationTest the concentration of S100B in participants

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 15, 2026